Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding
CtVNS
2 other identifiers
interventional
160
1 country
1
Brief Summary
This study aims to understand the role of the vagus nerve in promoting social bonding by using a non-invasive stimulation technique called transcutaneous vagal nerve stimulation (tVNS). The investigators will investigate whether tVNS can improve emotional, physiological, and behavioral experiences during and after social interactions. Couples will be randomly assigned to receive either tVNS or a sham stimulation during gratitude expression and problem-solving discussions. The investigators will measure their subjective evaluations of the interactions and capture their physiological and behavioral synchrony. This research will shed light on the processes involved in social connection and explore the potential of tVNS as a tool to enhance bonding in close relationships.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedStudy Start
First participant enrolled
February 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedResults Posted
Study results publicly available
May 4, 2025
CompletedMay 4, 2025
April 1, 2025
6 months
May 24, 2023
March 26, 2025
April 22, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Self-reported Positive Affect
During the conversation, overall, I felt… (1: not at all positive, 7: extremely positive)
Once, self-reported in a survey immediately following conflict interaction, up to 10 minutes
Self-reported Negative Affect
During the conversation, overall, I felt… (1: not at all negative, 7: extremely negative)
Once, self-reported in a survey immediately following conflict interaction, up to 10 minutes
Respiratory Sinus Arrhythmia
RSA was assessed continuously throughout the conversation.
Continuously throughout conflict conversation
Interbeat Interval
IBI was assessed continuously throughout the conversation.
Continuously throughout the conflict conversation
Study Arms (2)
Active tVNS
EXPERIMENTALWe will use a research edition of an auricular vagus nerve stimulator (tVNS RE, Vagus.net™, UK) that sends current-controlled stimulation in symmetric biphasic waveforms. The tVNS RE conforms to EU directive 93/42/EEC medical device standards and ISO/IEC 17050-1. This device consists of a handheld stimulator and an electrode clip. We will deliver stimulation at the individually calibrated intensity continuously during the interactions, and the default device settings we adopted were as follows: frequency = 30Hz, phase duration = 250μs, interphase interval = 50μs, and max voltage = 65V. In the active stimulation condition, both partners will have the stimulation clip attached to the outer auditory canal.
Sham tVNS
SHAM COMPARATORIn the sham condition, both partners will have electrodes attached to the center of the left ear lobe. They will still receive stimulation but at a placement that should not activate the vagus nerve.
Interventions
The intervention consists of neurostimulation device that is programmed to a stimulus intensity at 0.5mA with a stimulation frequency of 25 Hz at the outer auditory canal.
Eligibility Criteria
You may qualify if:
- Fluent in English
- Having been in a relationship with the partner for at least a year
- Within the age range of 18-39
You may not qualify if:
- Major chronic disease. self-reported autoimmune disease; severe asthma; lung disease (such as chronic bronchitis; history of stroke, heart attack, epilepsy, brain injury); cardiovascular disease.
- Cancer: if not in remission.
- Substance dependence-current or long history (5 years of more).
- Current psychiatric diagnosis that is not being treated with medication
- Confounding medications, including those used to treat hypertension and cardiovascular conditions; psychoactive substances; and medications known to directly affect autonomic functioning.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSF Nancy Friend Pritzker Psychiatry Building
San Francisco, California, 94107, United States
Related Publications (1)
Chung JM, Harari GM, Denissen JJ. Investigating the within-person structure and correlates of emotional experiences in everyday life using an emotion family approach. Journal of Personality and Social Psychology. 2022;122(6):1146-1189.
BACKGROUND
Results Point of Contact
- Title
- Dr. Yoobin Park
- Organization
- University of California, San Francisco
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participant couples will be blinded to their condition. Experimenters running the study will not be blinded since tVNS administration currently requires their knowledge of the condition.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2023
First Posted
June 12, 2023
Study Start
February 17, 2024
Primary Completion
July 31, 2024
Study Completion
July 31, 2024
Last Updated
May 4, 2025
Results First Posted
May 4, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
There is currently no plan to make individual participant data available to other researchers.